Global map of the economic cost burden due to vivax malaria and potential impact of radical cure.

(A) The baseline global costs, (B) the Supervised radical cure scenario, and (C) the Unsupervised radical cure scenario. Percentage change in total costs from the baseline global costs are shown for the radical cure scenarios. Costs are in 2017 United States Dollars. Countries in light grey are thought to have endemic P. vivax but insufficient information to generate case estimates. Countries in dark grey have insufficient cost data. Global national shapefile obtained from the Malaria Atlas Project (MAP; https://malariaatlas.org/) and available for download through the malariaAtlas R package.